| Literature DB >> 27861567 |
Tae Keun Yoo1, Sun Woong Kim2, Kyoung Yul Seo1.
Abstract
BACKGROUND: Previous research has suggested that immunoglobulin E (IgE)-mediated events lead to several chronic diseases. We investigated the association between allergic conditions and age-related cataracts in the South Korean adult population.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27861567 PMCID: PMC5115736 DOI: 10.1371/journal.pone.0166331
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flowchart of participant selection from the Korean National Health and Nutrition Examination Survey 2010.
Demographic and clinical characteristics of the study participants.
| Total participants (N = 1170) | Cataract or pseudophakia (N = 438) | No cataract (N = 732) | ||
|---|---|---|---|---|
| Age (years) | 55.0 ± 9.4 | 61.6 ± 8.2 | 51.1 ± 7.8 | <0.001 |
| Female (%) | 582 (49.7) | 255 (51.4) | 357 (48.8) | 0.398 |
| BMI (kg/m2) | 24.1 ± 2.9 | 24.2 ± 3.2 | 24.0 ± 2.8 | 0.127 |
| House income | ||||
| Very low (%) | 247 (21.3) | 135 (31.3) | 112 (15.4) | < 0.001 |
| Low (%) | 293 (25.3) | 112 (26.0) | 181 (24.9) | |
| Moderate (%) | 279 (24.1) | 92 (21.3) | 187 (25.8) | |
| High (%) | 338 (29.2) | 92 (21.3) | 246 (33.9) | |
| Education | ||||
| ≤ Middle school | 532 (46.0) | 274 (63.0) | 258 (35.7) | < 0.001 |
| ≥ High school | 625 (54.0) | 161 (37.0) | 464 (64.3) | |
| Region of residence | ||||
| Urban (%) | 898 (76.8) | 324 (74.0) | 574 (78.4) | 0.086 |
| Rural (%) | 272 (23.2) | 114 (26.0) | 158 (21.6) | |
| Smoking | ||||
| No smoking (%) | 629 (53.8) | 242 (55.3) | 387 (52.9) | 0.066 |
| Ex-smoking (%) | 264 (22.6) | 108 (24.7) | 156 (21.3) | |
| Current smoking (%) | 277 (23.7) | 88 (20.1) | 189 (25.8) | |
| Alcohol use (≥1 drink/week, %) | 511 (43.7) | 162 (37.0) | 349 (47.7) | <0.001 |
| Sun exposure | ||||
| <2 hours/day (%) | 679 (57.9) | 239 (54.6) | 440 (60.0) | 0.051 |
| 2–5 hours/day (%) | 299 (25.6) | 111 (25.3) | 188 (25.7) | |
| >5 hours/day (%) | 192 (16.4) | 88 (20.1) | 104 (14.2) | |
| Asthma (%) | 48 (4.1) | 21 (4.8) | 27 (3.7) | 0.365 |
| Atopic dermatitis (%) | 35 (3.0) | 12 (2.7) | 23 (3.2) | 0.727 |
| Rheumatoid arthritis (%) | 40 (3.4) | 18 (4.1) | 22 (3.0) | 0.323 |
| SBP (mmHg) | 122.8 ± 17.2 | 126.39 ± 17.0 | 120.7 ± 17.0 | <0.001 |
| DBP (mmHg) | 77.5 ± 10.3 | 76.7 ± 9.4 | 77.9 ± 10.8 | 0.036 |
| Fasting plasma glucose (mg/dL) | 101.3 ± 25.0 | 103.4 ± 24.6 | 100.1 ± 25.2 | 0.028 |
| Total cholesterol (mg/dL) | 193.7 ± 37.9 | 191.2 ± 37.5 | 195.3 ± 38.1 | 0.075 |
| Triglyceride (mg/dL) | 147.8 ± 116.4 | 146.7 ± 90.1 | 148.4 ± 129.7 | 0.797 |
| Increased total serum IgE (%) | 550 (47.0) | 233 (53.2) | 317 (43.3) | <0.001 |
| Sensitization to specific allergen | ||||
| | 394 (33.7) | 152 (34.7) | 242 (33.1) | 0.566 |
| Cockroaches (%) | 236 (20.2) | 90 (20.5) | 146 (19.9) | 0.822 |
| Dogs (%) | 51 (4.4) | 19 (4.3) | 32 (4.4) | 0.974 |
BMI, body mass index; DBP, diastolic blood pressure; IgE, immunoglobulin E; SBP, Systolic blood pressure.
Fig 2Prevalence of each cataract type within each age group in the Korean National Health and Nutrition Examination Survey 2010.
The prevalence of each cataract subtype in patients with various serum IgE levels.
| Serum IgE quartile (kU/L) | ||||||
|---|---|---|---|---|---|---|
| <35.0 | 35.0–37.6 | 37.7–267.0 | >267.0 | |||
| Cortical cataract | 12 | 29 | 22 | 26 | 0.038 | 0.084 |
| Nuclear cataract | 51 | 51 | 74 | 71 | 0.015 | 0.018 |
| Anterior subcapsular cataract | 1 | 3 | 3 | 0 | 0.740 | 0.608 |
| Posterior subcapsular cataract | 1 | 0 | 0 | 1 | 0.920 | 0.998 |
| Mixed cataract | 17 | 11 | 10 | 15 | 0.554 | 0.655 |
| Pseudophakia | 6 | 13 | 12 | 9 | 0.417 | 0.567 |
Logistic regression analysis of the association between age-related cataracts and demographic or clinical factors.
| Crude | Model 1 | Model 2 | ||||
|---|---|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | ||||
| Age (years) | 1.16 (1.14–1.18) | <0.001 | 1.16 (1.14–1.18) | <0.001 | 1.16 (1.14–1.18) | <0.001 |
| Female | 1.11 (0.87–1.40) | 0.390 | 1.01 (0.64–1.61) | 0.921 | 1.04 (0.68–1.58) | 0.851 |
| BMI (kg/m2) | 1.03 (0.99–1.07) | 0.116 | 0.99 (0.65–1.26) | 0.838 | 1.00 (0.95–1.05) | 0.992 |
| House income | ||||||
| Very low | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | |||
| Low | 0.51 (0.34–0.72) | < 0.001 | 1.09 (0.72–1.67) | 0.659 | 1.10 (0.72–1.84) | 0.644 |
| Moderate | 0.40 (0.28–0.58) | < 0.001 | 1.47 (0.94–2.31) | 0.088 | 1.49 (0.95–2.35) | 0.081 |
| High | 0.31 (0.21–0.43) | < 0.001 | 1.19 (0.76–1.85) | 0.428 | 1.19 (0.76–1.86) | 0.425 |
| Education | ||||||
| ≤ Middle school | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | |||
| ≥ High school | 0.32 (0.25–0.41) | < 0.001 | 1.01 (0.72–1.39) | 0.968 | 1.01 (0.72–1.39) | 0.975 |
| Region of residence | ||||||
| Urban | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | |||
| Rural | 1.27 (0.96–1.68) | 0.082 | 1.21 (0.86–1.70) | 0.274 | 1.21 (0.86–1.71) | 0.258 |
| Smoking | ||||||
| No smoking | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | |||
| Ex-smoking | 1.11 (0.82–1.48) | 0.496 | 1.00 (0.61–1.64) | 0.987 | 1.00 (0.61–1.64) | 0.991 |
| Current smoking | 0.74 (0.55–1.00) | 0.054 | 0.94 (0.56–1.57) | 0.824 | 0.94 (0.56–1.57) | 0.816 |
| Alcohol use (≥1 drinking/week) | 0.64 (0.50–0.82) | <0.001 | 0.91 (0.65–1.26) | 0.612 | 0.91 (0.65–1.27) | 0.588 |
| Sun exposure | ||||||
| <2 hours/day | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | |||
| 2–5 hours/day | 1.08 (0.81–1.44) | 0.563 | 0.82 (0.58–1.16) | 0.274 | 0.82 (0.58–1.16) | 0.278 |
| >5 hours/day | 1.55 (1.12–2.15) | 0.007 | 1.04 (0.70–1.53) | 0.842 | 1.03 (0.70–1.53) | 0.847 |
| Asthma | 1.31 (0.73–2.34) | 0.363 | 0.78 (0.38–1.61) | 0.514 | 0.78 (0.38–1.61) | 0.497 |
| Atopic dermatitis | 0.86 (0.42–1.75) | 0.689 | 0.90 (0.38–2.12) | 0.821 | 0.90 (0.38–2.12) | 0.875 |
| Rheumatoid arthritis | 1.37 (0.73–2.60) | 0.321 | 1.07 (0.50–2.27) | 0.858 | 1.06 (0.49–2.27) | 0.862 |
| SBP (mmHg) | 1.02 (1.01–1.03) | <0.001 | 1.00 (0.99–1.01) | 0.904 | 1.00 (0.99–1.01) | 0.924 |
| DBP (mmHg) | 0.99 (0.78–1.00) | 0.043 | 0.99 (0.97–1.01) | 0.400 | 0.99 (0.97–1.01) | 0.398 |
| Fasting plasma glucose (mg/dL) | 1.01 (1.00–1.01) | 0.030 | 1.00 (0.99–1.01) | 0.511 | 1.00 (0.99–1.01) | 0.491 |
| Total cholesterol (mg/dL) | 0.99 (0.99–1.00) | 0.076 | 0.99 (0.99–1.00) | 0.108 | 0.99 (0.99–1.00) | 0.103 |
| Triglyceride (mg/dL) | 1.00 (0.99–1.00) | 0.814 | 1.00 (0.99–1.00) | 0.819 | 1.00 (0.99–1.00) | 0.894 |
| Increased total serum IgE | 1.48 (1.17–1.88) | 0.001 | 1.36 (1.00–1.85) | 0.048 | 1.37 (1.01–1.86) | 0.044 |
| Sensitization to specific allergen | ||||||
| | 1.07 (0.83–1.38) | 0.565 | 1.12 (0.82–1.53) | 0.466 | 1.12 (0.82–1.54) | 0.450 |
| Cockroaches | 1.04 (0.77–1.39) | 0.804 | 0.86 (0.59–1.24) | 0.428 | 0.84 (0.58–1.22) | 0.387 |
| Dogs | 0.99 (0.55–1.77) | 0.974 | 0.89 (0.45–1.76) | 0.748 | 0.89 (0.45–1.78) | 0.761 |
BMI, body mass index; DBP, diastolic blood pressure; IgE, immunoglobulin E; SBP, Systolic blood pressure.
*Model 1 was adjusted for age, sex, body mass index, smoking, alcohol use, and sun exposure.
†Model 2 was adjusted for all of the factors in Model 1 and systolic blood pressure, fasting plasma glucose, total cholesterol, asthma, atopic dermatitis, and rheumatoid arthritis.
Odds ratios for the association of each cataract type with total and allergen-specific serum IgE.
| Increased total IgE | Sensitization to | Sensitization to Cockroaches | Sensitization to Dogs | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | |||||||
| Cortical cataract | ||||||||||
| Crude | 1.35 (0.87–2.08) | 0.175 | 1.11 (0.71–1.75) | 0.636 | 0.85 (0.49–1.50) | 0.592 | 0.23 (0.03–1.71) | 0.153 | ||
| Model 1 | 1.25 (0.78–2.01) | 0.344 | 1.17 (0.72–1.89) | 0.508 | 0.79 (0.44–1.43) | 0.795 | 0.23 (0.03–1.75) | 0.235 | ||
| Model 2 | 1.26 (0.78–2.03) | 0.333 | 1.18 (0.73–1.90) | 0.500 | 0.79 (0.43–1.43) | 0.792 | 0.24 (0.03–1.81) | 0.168 | ||
| Nuclear cataract | ||||||||||
| Crude | 1.60 (1.20–2.12) | 0.001 | 1.24 (0.93–1.67) | 0.137 | 1.28 (0.91–1.79) | 0.145 | 1.15 (0.59–2.24) | 0.668 | ||
| Model 1 | 1.41 (1.02–1.94) | 0.036 | 1.24 (0.90–1.72) | 0.185 | 1.14 (0.78–1.65) | 0.483 | 1.05 (0.52–2.12) | 0.885 | ||
| Model 2 | 1.42 (1.03–1.96) | 0.032 | 1.25 (0.90–1.74) | 0.170 | 1.13 (0.78–1.65) | 0.563 | 1.03 (0.51–2.08) | 0.926 | ||
| Anterior subcapsular cataract | ||||||||||
| Crude | 0.84 (0.18–3.79) | 0.826 | 0.33 (0.03–2.72) | 0.301 | 0.65 (0.07–5.49) | 0.699 | NA | NA | ||
| Model 1 | 0.80 (0.15–4.20) | 0.798 | 0.33 (0.03–2.93) | 0.320 | 0.71 (0.07–6.52) | 0.764 | NA | NA | ||
| Model 2 | 0.82 (0.15–4.37) | 0.817 | 0.29 (0.03–2.65) | 0.273 | 0.69 (0.07–6.65) | 0.749 | NA | NA | ||
| Posterior subcapsular cataract | ||||||||||
| Crude | 1.12 (0.07–18.69) | 0.932 | NA | NA | NA | NA | NA | NA | ||
| Model 1 | 1.95 (0.10–37.21) | 0.655 | NA | NA | NA | NA | NA | NA | ||
| Model 2 | 2.07 (0.10–41.15) | 0.632 | NA | NA | NA | NA | NA | NA | ||
| Mixed cataract | ||||||||||
| Crude | 0.93 (0.53–1.61) | 0.797 | 0.56 (0.29–1.08) | 0.086 | 0.49 (0.20–1.16) | 0.107 | NA | NA | ||
| Model 1 | 0.76 (0.40–1.41) | 0.389 | 0.59 (0.29–1.20) | 0.149 | 0.41 (0.16–1.03) | 0.060 | NA | NA | ||
| Model 2 | 0.81 (0.43–1.53) | 0.522 | 0.53 (0.26–1.10) | 0.100 | 0.39 (0.15–1.04) | 0.055 | NA | NA | ||
NA, not assessed (due to too low prevalence of each type of cataract).
*Model 1 was adjusted for age, sex, body mass index, smoking, alcohol use, and sun exposure.
†Model 2 was adjusted for all of the factors on Model 1 and systolic blood pressure, fasting plasma glucose, total cholesterol, asthma, atopic dermatitis, and rheumatoid arthritis.
Fig 3Effect of serum immunoglobulin E concentration on the odds ratios for each cataract subtype.
The odds ratios of anterior and posterior subcapsular cataracts were not assessed because of a low prevalence in our study population.
The prevalence and odds ratio of cataract in patients with and without an increased total serum IgE level.
Data from examined age groups are shown for comparison.
| Increased total IgE (Serum IgE ≥ 100 kU/L) | Not increased total IgE (Serum IgE < 100 kU/L) | Adjusted OR of increased total IgE for cataract | ||
|---|---|---|---|---|
| 40–49 years old | ||||
| Cataract or pseudophakia (%) | 21 (5.0) | 23 (5.5) | 0.220 | 1.40 (0.72–2.71) |
| No cataract (%) | 142 (34.1) | 230 (55.3) | ||
| 50–59 years old | ||||
| Cataract or pseudophakia (%) | 69 (17.7) | 64 (16.4) | 0.753 | 1.23 (0.76–2.01) |
| No cataract (%) | 128 (32.9) | 127 (32.7) | ||
| ≥60 years old | ||||
| Cataract or pseudophakia (%) | 143 (39.0) | 118 (32.2) | 0.083 | 1.54 (0.93–2.53) |
| No cataract (%) | 47 (12.8) | 58 (15.8) |
*Adjusted for age, sex, body mass index, smoking, alcohol use, sun exposure, systolic blood pressure, fasting plasma glucose, total cholesterol, asthma, atopic dermatitis, and rheumatoid arthritis.